الوصف

Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation.

Figure 2

Chart

Source Paper

Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.

Acta pharmacologica Sinica (2021)

PMID: 33558654

DOI: 10.1038/s41401-020-00601-4

Cite This Figure

![Figure 2: Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation.]()

> Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." *Acta pharmacologica Sinica*, 2021. PMID: [33558654](https://pubmed.ncbi.nlm.nih.gov/33558654/)

<figure>
  <img src="" alt="Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation." />
  <figcaption>Figure 2. Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation.<br>  Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." <em>Acta pharmacologica Sinica</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33558654/">33558654</a></figcaption>
</figure>

أدلة ذات صلة

Berberine لـ Gut Dysbiosis

التقييم D · 2 دراسات